 SEATTLE, WA and VANCOUVER, BC ACCESSWIRE September 15, 2021 Achieve Life Sciences, Inc. NASDAQ:ACHV, a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that John Bencich, Chief Executive Officer, will participate in two upcoming investor conferences. Mr. Bencich will present at the virtual Oppenheimer Fall Healthcare Life Sciences MedTech Summit on Tuesday, September 21st at 3:45PM ET. 